| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients
|
Monagle, Paul
|
|
|
9 |
10 |
p. 2587-2636
|
artikel
|
| 2 |
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
|
Shaw, Reid
|
|
|
9 |
10 |
p. 2453-2457
|
artikel
|
| 3 |
ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells
|
Kost, Sara E. F.
|
|
|
9 |
10 |
p. 2422-2427
|
artikel
|
| 4 |
Breaking the cycle: PRMTs and secondary HLH relief
|
Malik, Sakshi
|
|
|
9 |
10 |
p. 2436-2437
|
artikel
|
| 5 |
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France
|
Bigenwald, Camille
|
|
|
9 |
10 |
p. 2530-2541
|
artikel
|
| 6 |
Cytogenetic annotation automation in myelodysplastic syndrome research databases
|
Urrutia, Samuel
|
|
|
9 |
10 |
p. 2428-2430
|
artikel
|
| 7 |
Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation
|
Chiang, Cho-Han
|
|
|
9 |
10 |
p. 2410-2418
|
artikel
|
| 8 |
Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencing
|
Wen, Ting
|
|
|
9 |
10 |
p. 2443-2452
|
artikel
|
| 9 |
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma
|
Potdar, Sayalee V.
|
|
|
9 |
10 |
p. 2438-2442
|
artikel
|
| 10 |
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
|
Hyder, Mustafa A.
|
|
|
9 |
10 |
p. 2553-2569
|
artikel
|
| 11 |
John TD, Walters MC, Rangarajan HG, et al. Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease. Blood Adv. 2024;8(23):6055-6063.
|
|
|
|
9 |
10 |
p. 2460
|
artikel
|
| 12 |
Kuaban A, Croker AK, Keefer J, et al. The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative. Blood Adv. 2025;9(4):687-695.
|
|
|
|
9 |
10 |
p. 2637
|
artikel
|
| 13 |
Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia
|
Goede, Valentin
|
|
|
9 |
10 |
p. 2431-2435
|
artikel
|
| 14 |
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model
|
Gamal, Wael
|
|
|
9 |
10 |
p. 2511-2529
|
artikel
|
| 15 |
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study
|
Westin, Jason
|
|
|
9 |
10 |
p. 2461-2472
|
artikel
|
| 16 |
Nilotinib attenuates vascular pathology in experimental cerebral malaria
|
Ortolan, Luana S.
|
|
|
9 |
10 |
p. 2473-2488
|
artikel
|
| 17 |
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study
|
Phina-Ziebin, Xavier
|
|
|
9 |
10 |
p. 2500-2510
|
artikel
|
| 18 |
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
|
Politikos, Ioannis
|
|
|
9 |
10 |
p. 2570-2584
|
artikel
|
| 19 |
PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosis
|
Brown-Burke, Fiona
|
|
|
9 |
10 |
p. 2379-2392
|
artikel
|
| 20 |
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques
|
Petty, Nicholas E.
|
|
|
9 |
10 |
p. 2367-2378
|
artikel
|
| 21 |
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa
|
Mawalla, William Frank
|
|
|
9 |
10 |
p. 2393-2401
|
artikel
|
| 22 |
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non–low-risk AML
|
Marconi, Giovanni
|
|
|
9 |
10 |
p. 2542-2552
|
artikel
|
| 23 |
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study
|
Hu, Bei
|
|
|
9 |
10 |
p. 2489-2499
|
artikel
|
| 24 |
The preclinical profile of SerpinPC: a potential new treatment for hemophilia
|
Huntington, James A.
|
|
|
9 |
10 |
p. 2402-2409
|
artikel
|
| 25 |
Tocilizumab prophylaxis in double cord blood transplantation
|
Drobyski, William R.
|
|
|
9 |
10 |
p. 2585-2586
|
artikel
|
| 26 |
Weighing the evidence on GLP1s and venous thromboembolism
|
Houghton, Damon E.
|
|
|
9 |
10 |
p. 2458-2459
|
artikel
|
| 27 |
What to do with the weight while preparing for CAR-T?
|
Yates, Samuel J.
|
|
|
9 |
10 |
p. 2419-2421
|
artikel
|
Tijdschrift beschrijving